Connecting G protein-coupled estrogen receptor biomolecular mechanisms with the pathophysiology of preeclampsia: a review.
Connecting G protein-coupled estrogen receptor biomolecular mechanisms with the pathophysiology of preeclampsia: a review.
复制标题
DOI:
10.1186/s12958-023-01112-7
复制
发表时间:
2023-07-01
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Throughout the course of pregnancy, small maternal spiral arteries that are in contact with fetal tissue undergo structural remodeling, lose smooth muscle cells, and become less responsive to vasoconstrictors. Additionally, placental extravillous trophoblasts invade the maternal decidua to establish an interaction between the fetal placental villi with the maternal blood supply. When successful, this process enables the transport of oxygen, nutrients, and signaling molecules but an insufficiency leads to placental ischemia. In response, the placenta releases vasoactive factors that enter the maternal circulation and promote maternal cardiorenal dysfunction, a hallmark of preeclampsia (PE), the leading cause of maternal and fetal death. An underexplored mechanism in the development of PE is the impact of membrane-initiated estrogen signaling via the G protein-coupled estrogen receptor (GPER). Recent evidence indicates that GPER activation is associated with normal trophoblast invasion, placental angiogenesis/hypoxia, and regulation of uteroplacental vasodilation, and these mechanisms could explain part of the estrogen-induced control of uterine remodeling and placental development in pregnancy. Although the relevance of GPER in PE remains speculative, this review provides a summary of our current understanding on how GPER stimulation regulates some of the features of normal pregnancy and a potential link between its signaling network and uteroplacental dysfunction in PE. Synthesis of this information will facilitate the development of innovative treatment options.
登录
查看更多内容
影响因子:
3.7
作者:
Dechanet C;Fort A;Barbero-Camps E;Dechaud H;Richard S;Virsolvy A
通讯作者:
Virsolvy A
DOI:
10.1136/bmj.f6564
发表时间:
2013-11-07
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Ananth CV;Keyes KM;Wapner RJ
通讯作者:
Wapner RJ
影响因子:
7.2
作者:
通讯作者:
--
影响因子:
9.8
作者:
Brosens, Ivo;Brosens, Jan J.;Benagiano, Giuseppe
通讯作者:
Benagiano, Giuseppe
影响因子:
1.2
作者:
Cheng, Ching-Yi;Hsieh, Hsi-Lung;Yang, Chuen-Mao
通讯作者:
Yang, Chuen-Mao